| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |